Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
0z9r4Knpwv5WBNYL
Listen
